On June 12, Changguang Chenxin rose 9.14% in regular trading, trading at HK$97.15/share, with turnover of HK$13.77 million, marking a strong rebound following consecutive sessions of volatility.

On the news front, Guotai Haitong Securities initiated coverage on Changguang Chenxin with an Overweight rating and a target price of HK$112.86, representing significant upside from current levels. The broker projects revenue of RMB 1.196/1.571/1.916 billion and net profit of RMB 482/693/906 million for 2026-2028, applying a 63x PE multiple based on comparable semiconductor peers. The firm highlighted the company's position as a top-three global player in both industrial and scientific imaging CIS by revenue, with strong technology and customer barriers. Additionally, CLSA had previously initiated coverage with an Outperform rating and a HK$141.2 target price, further reinforcing institutional optimism. The dual endorsement from major brokerages appears to have lifted sentiment following a period of selling pressure triggered by shareholder Singapore Tianzhi's planned disposal of up to 1.5221 million shares.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)